PL2906531T3 - Związki użyteczne w syntezie związków benzamidowych - Google Patents

Związki użyteczne w syntezie związków benzamidowych

Info

Publication number
PL2906531T3
PL2906531T3 PL13846466T PL13846466T PL2906531T3 PL 2906531 T3 PL2906531 T3 PL 2906531T3 PL 13846466 T PL13846466 T PL 13846466T PL 13846466 T PL13846466 T PL 13846466T PL 2906531 T3 PL2906531 T3 PL 2906531T3
Authority
PL
Poland
Prior art keywords
compounds
synthesis
benzamide
useful
compounds useful
Prior art date
Application number
PL13846466T
Other languages
English (en)
Inventor
Mario Emilov Lozanov
Anthony Frank Skufca
Andrew George Zeiler
Original Assignee
Resverlogix Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resverlogix Corp. filed Critical Resverlogix Corp.
Publication of PL2906531T3 publication Critical patent/PL2906531T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL13846466T 2012-10-15 2013-10-09 Związki użyteczne w syntezie związków benzamidowych PL2906531T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261713711P 2012-10-15 2012-10-15
PCT/IB2013/003031 WO2014060852A2 (en) 2012-10-15 2013-10-09 Compounds useful in the synthesis of benzamide compounds
EP13846466.4A EP2906531B1 (en) 2012-10-15 2013-10-09 Compounds useful in the synthesis of benzamide compounds

Publications (1)

Publication Number Publication Date
PL2906531T3 true PL2906531T3 (pl) 2018-04-30

Family

ID=50475926

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13846466T PL2906531T3 (pl) 2012-10-15 2013-10-09 Związki użyteczne w syntezie związków benzamidowych

Country Status (25)

Country Link
US (1) US8884046B2 (pl)
EP (1) EP2906531B1 (pl)
JP (2) JP6307087B2 (pl)
KR (1) KR101532570B1 (pl)
CN (1) CN104884427B (pl)
AU (1) AU2013333575B2 (pl)
BR (1) BR112015008389B1 (pl)
CA (1) CA2888378C (pl)
CY (1) CY1119862T1 (pl)
DK (1) DK2906531T3 (pl)
ES (1) ES2658221T3 (pl)
HR (1) HRP20180176T1 (pl)
HU (1) HUE036421T2 (pl)
IL (2) IL238186A (pl)
LT (1) LT2906531T (pl)
MX (1) MX338885B (pl)
NO (1) NO2992016T3 (pl)
NZ (1) NZ707276A (pl)
PL (1) PL2906531T3 (pl)
PT (1) PT2906531T (pl)
RS (1) RS56846B1 (pl)
RU (1) RU2593752C1 (pl)
SA (1) SA515360284B1 (pl)
SI (1) SI2906531T1 (pl)
WO (1) WO2014060852A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2676984C (en) 2007-02-01 2015-03-17 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
WO2010106436A2 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Novel anti-inflammatory agents
AU2010239266B2 (en) 2009-04-22 2015-01-22 Resverlogix Corp. Novel anti-inflammatory agents
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
WO2016147053A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118752D0 (en) * 2001-08-01 2001-09-26 Pfizer Ltd Process for the production of quinazolines
GB0206033D0 (en) * 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
US20050080021A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
US20050080024A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20040033480A1 (en) 2002-08-15 2004-02-19 Wong Norman C.W. Use of resveratrol to regulate expression of apolipoprotein A1
WO2005034960A1 (en) 2003-10-10 2005-04-21 Resverlogix Corp. Treatment of diseases associated with the egr-1 enhancer element
GB0512324D0 (en) * 2005-06-16 2005-07-27 Novartis Ag Organic compounds
CA2584507C (en) 2004-10-20 2016-04-26 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
EP2314295B1 (en) 2005-07-29 2015-01-28 Resverlogix, Inc Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CA2676984C (en) 2007-02-01 2015-03-17 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US20110053932A1 (en) * 2007-06-21 2011-03-03 Irm Llc Protein Kinase Inhibitors and Methods for Using Thereof
CA2711103C (en) 2008-06-26 2016-08-09 Resverlogix Corp. Methods of preparing quinazolinone derivatives
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
WO2010106436A2 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Novel anti-inflammatory agents
AU2010239266B2 (en) 2009-04-22 2015-01-22 Resverlogix Corp. Novel anti-inflammatory agents
GB201007286D0 (en) * 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
DE102010048800A1 (de) * 2010-10-20 2012-05-10 Merck Patent Gmbh Chinoxalinderivate
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
CN104918912B (zh) * 2012-10-15 2017-02-22 阿尔比马尔公司 2‑氨基‑4,6‑二甲氧基苯甲酰胺和其他苯甲酰胺化合物的合成方法
TWI574789B (zh) * 2012-11-13 2017-03-21 氣體產品及化學品股份公司 漿料供應及/或化學品摻合物供應設備、方法、使用方法及製造方法

Also Published As

Publication number Publication date
PT2906531T (pt) 2018-02-06
DK2906531T3 (en) 2018-02-05
ES2658221T3 (es) 2018-03-08
WO2014060852A2 (en) 2014-04-24
HUE036421T2 (hu) 2018-07-30
NZ707276A (en) 2016-02-26
KR101532570B1 (ko) 2015-06-30
NO2992016T3 (pl) 2018-03-17
CN104884427B (zh) 2016-09-07
HRP20180176T1 (hr) 2018-03-09
BR112015008389B1 (pt) 2020-12-15
LT2906531T (lt) 2018-02-26
SA515360284B1 (ar) 2016-04-19
HK1207623A1 (en) 2016-02-05
EP2906531A2 (en) 2015-08-19
RS56846B1 (sr) 2018-04-30
RU2593752C1 (ru) 2016-08-10
US8884046B2 (en) 2014-11-11
CA2888378C (en) 2015-09-22
JP2015531403A (ja) 2015-11-02
CA2888378A1 (en) 2014-04-24
US20140107369A1 (en) 2014-04-17
BR112015008389A2 (pt) 2017-07-04
WO2014060852A3 (en) 2014-07-24
EP2906531A4 (en) 2016-06-01
JP6307087B2 (ja) 2018-04-04
KR20150061661A (ko) 2015-06-04
IL238186A (en) 2016-03-31
MX338885B (es) 2016-05-04
IL244099A0 (en) 2016-04-21
AU2013333575A1 (en) 2015-05-28
CY1119862T1 (el) 2018-06-27
MX2015004764A (es) 2015-08-14
AU2013333575B2 (en) 2015-07-16
SI2906531T1 (en) 2018-03-30
EP2906531B1 (en) 2018-01-17
JP2017088632A (ja) 2017-05-25
CN104884427A (zh) 2015-09-02

Similar Documents

Publication Publication Date Title
ZA201408429B (en) Methods for the synthesis of ethylfumarates and their use as intermediates
PT2875062T (pt) Processo de síntese de poliarilétercetonas
HUE044300T2 (hu) 3-amino-cikloalkil-vegyületek, mint ROR-GAMMA-T inhibitorok és alkalmazásuk
IL237309A0 (en) Benzocyclooctyne compounds and uses thereof
IL225350A0 (en) Converted benzamide compounds
SG10201703051WA (en) Compounds and methods for the production of suckerin and uses thereof
IL244099A0 (en) Compounds useful in the synthesis of benzamide compounds
AP2015008406A0 (en) Benzamides
SG11201406871UA (en) Benzamide derivative
ZA201308401B (en) Substituted benzamide derivatives
GB201216800D0 (en) Novel use
GB201111630D0 (en) Novel compounds and their use
GB201218352D0 (en) Compounds and their synthesis
ZA201207903B (en) Novel benzamide derivatives
PL2882708T3 (pl) Nowe związki i ich zastosowania
EP2852607A4 (en) IMPROVED SYNTHESIS
GB201212463D0 (en) Novel use
GB201216782D0 (en) Synthesis of MOFs
GB201213726D0 (en) Novel compounds and their use
GB201220558D0 (en) Novel compounds 1
GB201206730D0 (en) Novel compounds 1
IL216586A0 (en) 3d-layout of the two tablets of testimony
GB201202256D0 (en) Novel use
GB201222342D0 (en) Compounds and uses thereof
GB201206973D0 (en) New compounds and uses